A Possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier
- 31 March 1999
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 35 (3), 459-466
- https://doi.org/10.1016/s0959-8049(98)00373-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- HPMA copolymer–anticancer drug–OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitroInternational Journal of Cancer, 1998
- ABNORMAL DIFFERENTIATION OF THYMOCYTES INDUCED BY FREE CYCLOSPORINE IS AVOIDED WHEN CYCLOSPORINE BOUND TO N-(2-HYDROXYPROPYL) METHACRYLAMIDE COPOLYMER CARRIER IS USED1Transplantation, 1997
- Comparison of the binding kinetics of antibody-targeted N-(2-hydroxypropyl) methacrylamide (HPMA)-bound doxorubicin in vitro and in vivoJournal of Controlled Release, 1996
- Hypersensitization of Multidrug Resistant Human Ovarian Carcinoma Cells by Pluronic P85 Block CopolymerBioconjugate Chemistry, 1996
- Myeloid and lymphoid cell alterations in normal mice exposed to chemotherapy with doxorubicin and/or the multidrug‐resistance reversing agent SDZ PSC 833International Journal of Cancer, 1994
- Drug-polymer conjugatesAnti-Cancer Drugs, 1992
- Coclustering CD45 with CD4 or CD8 alters the phosphorylation and kinase activity of p56lck.The Journal of Experimental Medicine, 1990
- Action of polymeric prodrugs based on N-(2-hydroxypropyl)-methacrylamide copolymers. II. Body distribution and T-cell accumulation of free and polymer-bound [125i]daunomycinJournal of Controlled Release, 1989
- Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin: Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitroBiomaterials, 1989
- Antibody-directed affinity therapy applied to the immune system: In vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibodyClinical Immunology and Immunopathology, 1988